Furthermore, a growing body of evidence indicates that the activation of IL-17 signaling induces the expression of inflammatory transcription factors via the NF-κB and MAPK pathways, resulting in cancer formation and progression [65,66,67]. This evidence concerns the gene NFKB1 and cancer.